P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

Detalles Bibliográficos
Autores principales: Sperling, A. S., Nikiforow, S., Derman, B., Nadeem, O., Mo, C., Laubach, J., Anderson, K., Alonso, A., Im, S.-Y., Ikwgawa, S., Prabhala, R., Hernandez Rodriduez, D., Daley, H., Shaw, K. L., Arihara, Y., Ansari, S., Quinn, D. S., Pearson, D., Hack, A., Treanor, L., Bu, D., Mataraza, J., Rispoli, L., Credi, M., Ritz, J., Jakubowiak, A., De Vita, S., Munshi, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430604/
http://dx.doi.org/10.1097/01.HS9.0000848640.53562.8f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430604/
http://dx.doi.org/10.1097/01.HS9.0000848640.53562.8f

Ejemplares similares